These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Aspirin and the prevention of stroke after transient ischaemic attack. Warlow C Monogr Atheroscler; 1986; 14():203-6. PubMed ID: 3526126 [No Abstract] [Full Text] [Related]
5. Does platelet antiaggregant therapy lessen the severity of stroke? Grotta JC; Lemak NA; Gary H; Fields WS; Vital D Neurology; 1985 May; 35(5):632-6. PubMed ID: 3887210 [TBL] [Abstract][Full Text] [Related]
6. Multicenter trials in stroke. Hachinski V Arch Neurol; 1990 Apr; 47(4):445. PubMed ID: 2322139 [No Abstract] [Full Text] [Related]
7. The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group. Lancet; 1987 Dec; 2(8572):1351-4. PubMed ID: 2890951 [TBL] [Abstract][Full Text] [Related]
8. Effectively bridging the preclinical/clinical gap: the results of the ASTIN trial. Sughrue ME; Connolly ES Stroke; 2004 Apr; 35(4):e81-2; author reply e81-2. PubMed ID: 14988564 [No Abstract] [Full Text] [Related]
9. Stroke drug development: usually, but not always, animal models. Donnan GA; Davis SM Stroke; 2005 Oct; 36(10):2326. PubMed ID: 16141427 [No Abstract] [Full Text] [Related]
10. Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke. Bath PM; Macleod MR; Green AR Int J Stroke; 2009 Dec; 4(6):471-9. PubMed ID: 19930059 [TBL] [Abstract][Full Text] [Related]
11. Clinical trials in the secondary prevention of myocardial infarction and stroke. Armitage P Thromb Haemost; 1980 Jun; 43(2):90-8. PubMed ID: 7455980 [No Abstract] [Full Text] [Related]
12. Sample size for randomized trials in stroke prevention. How many patients do we need? Taylor DW; Sackett DL; Haynes RB Stroke; 1984; 15(6):968-71. PubMed ID: 6506126 [No Abstract] [Full Text] [Related]
13. Use of animal models has not contributed to development of acute stroke therapies: pro. Kaste M Stroke; 2005 Oct; 36(10):2323-4. PubMed ID: 16141431 [No Abstract] [Full Text] [Related]
14. Use of animal models has not contributed to development of acute stroke therapies: con. Fisher M; Tatlisumak T Stroke; 2005 Oct; 36(10):2324-5. PubMed ID: 16141429 [No Abstract] [Full Text] [Related]
15. Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group N Engl J Med; 1988 Jan; 318(4):262-4. PubMed ID: 3275899 [No Abstract] [Full Text] [Related]
16. Randomized trial of therapy with platelet antiaggregants for threatened stroke. The Canadian Cooperative Stroke Study Group Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457 [No Abstract] [Full Text] [Related]